Summary & Overview
HCPCS Level II Q0521: Pharmacy Supply for HIV Pre-Exposure Prophylaxis
HCPCS Level II code Q0521 denotes a pharmacy supplying fee associated with an FDA‑approved prescription for HIV pre‑exposure prophylaxis (PrEP). As PrEP use expands for HIV prevention, a specific pharmacy supply code helps standardize billing for dispensing-related services and supports clearer reimbursement pathways for pharmacies and payers nationally. This matters for access to prevention services, pharmacy cash flow, and consistent claims processing.
Key payers in the national context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what Q0521 represents clinically and operationally, typical sites of service, the common modifiers used with the code, and guidance on where to find related coding and billing considerations. The publication summarizes payer coverage patterns, benchmarks where available, and relevant policy and reimbursement updates affecting pharmacy‑supplied PrEP services.
The content provides clinical context for PrEP dispensing, outlines common modifiers associated with pharmacy supply billing, and lists practical billing considerations and related codes or documentation needs. Data not available in the input is noted where appropriate.
Billing Code Overview
HCPCS Level II code Q0521 describes a pharmacy supplying fee for HIV pre-exposure prophylaxis FDA-approved prescription. The code represents a billing entry for a pharmacy-provided service tied to dispensing and associated pharmacy supply activities related to an FDA-approved HIV pre-exposure prophylaxis prescription.
Service Type: Pharmacy supplying fee for HIV pre-exposure prophylaxis
Typical Site of Service: Pharmacy
Clinical & Coding Specifications
Clinical Context
A 28-year-old sexually active man who has sex with men presents to a community health clinic requesting HIV prevention services. After a risk assessment and documented negative HIV test, a clinician prescribes FDA‑approved HIV pre‑exposure prophylaxis (PrEP). The clinic’s pharmacy prepares the prescription and records the pharmacy supplying fee associated with dispensing the PrEP medication, billed under Q0521. The clinical workflow includes: initial visit with sexual history and baseline laboratory testing (HIV antigen/antibody, creatinine, hepatitis B serology), counseling on adherence and risk reduction, electronic prescription sent to the dispensing pharmacy, pharmacist verification and counseling at pick up, and documentation of the dispensing event. The pharmacy documents quantity dispensed, days’ supply, and counseling provided, then submits the Q0521 supply fee to the patient’s payor alongside the drug NDC/HCPCS when applicable. Follow‑up visits for HIV testing and renal monitoring occur every 3 months per standard protocols.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no special circumstance applies to the pharmacy supplying fee. |